Company

Our
Company

We are more than a radioisotope supplier. We are solving the challenges facing U.S. radioisotope customers and constantly evolving to meet changing needs.

IN OUR EFFORTS TO DELIVER
CREATIVE SOLUTIONS, WE
CLEARLY DEFINE

WHO
WE ARE

We are innovators who revolutionized the reliable production of Mo-99. We are dedicated to preserving the environment using non-uranium production methods. We are pioneers working with industry leaders to develop and commercialize new diagnostics and therapeutics that will serve the next generation of medical advances for patients.

THE RADIOPHARMACEUTICAL MARKET
DEMANDS CREATIVE, ORIGINAL
THINKING, LIKE THAT PIONEERED BY OUR

LEADERSHIP
TEAM

Our executive team brings proven experience and expertise in developing and commercializing innovative nuclear medicine products and technologies.

LATEST NEWS, PRESS RELEASES & EVENTS


News - Nov 23, 2022
From isotopes to internships, UW-Madison partnership energizes growing Wisconsin company

Press Releases - Nov 18, 2022
NorthStar Medical Radioisotopes Statement on Availability of Technetium 99m Generators and the FDA Drug Shortages List

Press Releases - Nov 15, 2022
NorthStar Medical Radioisotopes Expands Business Platform with New, Patient-focused, Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) Services Unit
Oct 21, 2022 - Oct 22, 2022
Virtual Event
Florida Pharmacy Association (FPA) 2022 Midyear Nuclear Conference
Speaking